| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGR2
|
anterior gradient 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA2
|
annexin A2
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ASL
|
argininosuccinate lyase
|
|
ATF3
|
activating transcription factor 3
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
C3
|
complement component 3
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCNA1
|
cyclin A1
|
|
CCNB1
|
cyclin B1
|
|
CCNB2
|
cyclin B2
|
|
CCND1
|
cyclin D1
|
|
CCR10
|
chemokine (C-C motif) receptor 10
|
|
CD38
|
CD38 molecule
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CELF1
|
CUGBP, Elav-like family member 1
|
|
CFH
|
complement factor H
|
|
CHKB
|
choline kinase beta
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENG
|
endoglin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA2
|
EPH receptor A2
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FADS1
|
fatty acid desaturase 1
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FDFT1
|
farnesyl-diphosphate farnesyltransferase 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3
|
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GPX1
|
glutathione peroxidase 1
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HTATSF1
|
HIV-1 Tat specific factor 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IL10
|
interleukin 10
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
ING1
|
inhibitor of growth family, member 1
|
|
INSR
|
insulin receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
IVL
|
involucrin
|
|
KDR
|
kinase insert domain receptor
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KRT19
|
keratin 19, type I
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
LEP
|
leptin
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LPL
|
lipoprotein lipase
|
|
MAD2L1BP
|
MAD2L1 binding protein
|
|
MAPT
|
microtubule-associated protein tau
|
|
MC4R
|
melanocortin 4 receptor
|
|
MGAM
|
maltase-glucoamylase
|
|
MLH1
|
mutL homolog 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYLK
|
myosin light chain kinase
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NEFH
|
neurofilament, heavy polypeptide
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDPN
|
podoplanin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PF4
|
platelet factor 4
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PKM
|
pyruvate kinase, muscle
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRLR
|
prolactin receptor
|
|
PRM1
|
protamine 1
|
|
PRM2
|
protamine 2
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROS1
|
protein S (alpha)
|
|
PSEN1
|
presenilin 1
|
|
PSEN2
|
presenilin 2
|
|
PSENEN
|
presenilin enhancer gamma secretase subunit
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
S100B
|
S100 calcium binding protein B
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMN2
|
survival of motor neuron 2, centromeric
|
|
SP3
|
Sp3 transcription factor
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRSF3
|
serine/arginine-rich splicing factor 3
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
SYNC
|
syncoilin, intermediate filament protein
|
|
SYNM
|
synemin, intermediate filament protein
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TF
|
transferrin
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
THBS1
|
thrombospondin 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNNT1
|
troponin T type 1 (skeletal, slow)
|
|
TP53
|
tumor protein p53
|
|
TRIM5
|
tripartite motif containing 5
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UGT1A
|
UDP glucuronosyltransferase 1 family, polypeptide A complex locus
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VWF
|
von Willebrand factor
|
|
ZFP36
|
ZFP36 ring finger protein
|
